Corporate Sustainability Report

Overview

The report presents JB Pharma's FY2022-23 sustainability performance across eight manufacturing sites, an R&D office and headquarters. It reports 10096.64 tCO2e of Scope 1 emissions, 45281.95 tCO2e of Scope 2 emissions and 136837.62 tCO2e of Scope 3 emissions, while renewable energy reached 8464.89GJ. It also highlights zero workplace fatalities and 16.67% Board gender diversity.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2022-2023
Period: 1 April 2022 – 31 March 2023
Language: English
Pages
File size
Restatement: Disclosed

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Commitments

UN Global Compact
UN Guiding Principles
Science Based Targets initiative

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Provider
Level
Standard
Scope
Statement included
Metrics assured

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services